With increasing resistance to existing antibiotics and little incentive for pharmaceutical companies to invest in new ones, developing countries face a serious challenge combating killer diseases such as tuberculosis and…
ARE ANTIBIOTICS BECOMING A ‘NON SUSTAINABLE’ DRUG SUPPLY?
CHINESE EXPORTS: DANGER, REGULATION AND SECURITY
By GERRY BLOOM, STEPS Centre member Over the past few months there have been a number of stories in the international media about dangerous exports from China. On the one…
Cotton farming in Hubei province
By ADRIAN ELY, STEPS Centre member In Hubei Province, I was fortunate to be able to visit two villages and, with the help of an interpreter, talk to several local…
RISK IN INDIA: NEW PHARMACEUTICALS & PATENT LAW
By ESHA SHAH, STEPS Centre member Controversy over the extent to which private pharmaceutical interests can creep into the debates around public good has arisen recently here in India. A…
RISK, UNCERTAINTY AND EMERGING TECHNOLOGIES IN INDIA
By ESHA SHAH, STEPS Centre member Our time is marked by a rapid technological change and associated anxieties about public and private risks, a significant part of which remain uncertain…